Blood is a weekly medical journal published by the American Society of Hematology. It was founded by Dr. William Dameshek, the researcher credited with describing the concept of myeloproliferative diseases and participating in the first studies of nitrogen mustard in various blood malignancies, in 1946, and has since been in continuous publication.
With 1,364 articles published annually, an impact factor of 10.558, and an Immediacy Index of 1.980, Blood is the most cited peer-reviewed publication in the field. It provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. The journal covers all aspects of hematology, including disorders of leukocytes, both benign and malignant, erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology, and hematologic oncology.
CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines:
head and neck disease
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology and course of human cancer. CANCER accomplishes this objective by publishing original articles, as well as other scientific and educational documents, that support the mission of the American Cancer Society by facilitating the transfer of knowledge from the laboratory to the bedside; contributing to cancer prevention, early detection, diagnosis, cure, and rehabilitation; and diminishing suffering from cancer.
Cancer Cell publishes exciting and highly significant studies in a broad range of cancer research, from those elucidating significant advances in understanding the disease processes of cancer to those establishing new paradigms in the diagnosis, treatment, and prevention of cancers. Examples of areas covered by Cancer Cell are:
- Molecular and cellular mechanisms of fundamental cancer biology, such as apoptosis, cell cycle/checkpoint regulation, the genetics and epigenetics of tumorigenesis, angiogenesis and lymphangiogenesis, invasion, metastasis, and host immune responses to cancer.
- Cancer therapeutics research, including the elucidation of mechanisms for the sensitivity and the resistance to current cancer therapies, identification of new therapeutic targets, and development of new cancer therapies.
- Identification of new markers for classification, diagnosis, or prognosis of cancers, or for prediction of response to treatments with clear clinical significance.
- Development and analysis of tumor models that enhance our understanding of human tumor development and/or that improve preclinical testing of diagnostic, treatment and prevention strategies for cancer patients.
The journal publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention and epidemiological research. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. The main scope of the Journal is captured in its primary subsections, which focus on molecular and cellular pathobiology, tumor and stem cell biology, therapeutics and targets, microenvironment and immunology, prevention and epidemiology, and integrated systems and technology.
The European Journal of Cancer (including EJC Supplements), is an international comprehensive oncology journal that publishes original research, editorial comments, review articles and news on basic and preclinical research, clinical oncology (medical, paediatric, radiation, surgical), and on cancer epidemiology and prevention. EJC Supplements is ... click here for full Aims & Scope
Gastroenterology is the most prominent journal in the field of gastrointestinal disease. As the official journal of the AGA Institute, Gastroenterology delivers up-to-date and authoritative coverage of both basic and clinical gastroenterology. Regular features include articles by leading authorities and reports on the latest treatments for diseases. Original research is organized by clinical and basic-translational content, as well as by alimentary tract, liver, pancreas, and biliary content. Gastroenterology also bridges the gap between basic and clinical science by publishing comprehensive reviews and perspectives on important topics such as pancreatitis and liver disease. Additional features include Covering the Cover; Mentoring, Training, and Education Corner; Press Highlights; Imaging and Advanced Technology; Clinical Challenges and Images in GI; Selected Summaries; Print and Digital Media Reviews; Continuing Medical Education Activities; Editorials; and Correspondence.
The premier publication in the field of liver disease, Hepatology publishes original, peer-reviewed articles concerning all aspects of liver structure, function and disease. Each month, the distinguished Editorial Board monitors and selects only the best articles on subjects such as immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases and their complications, liver cancer, and drug metabolism.
Molecular Oncology highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational research. Topics include:
• Key biological processes such as cell cycle; DNA repair; apoptosis; invasion and metastasis; angiogenesis and lymphangiogenesis; cell signalling and interactive networks; immune response.
• Emerging technologies (genomics, proteomics, functional genomics, metabolomics, tissue arrays, imaging), and model systems.
•Biomarkers: diagnosis, prognosis, stratification and efficacy.
• Cancer genetics, epigenetics, and genomic instability.
• Minimal residual disease, pre-malignant lesions.
• Cancer micro-environment.
• Molecular pathology.
• Tumour immunology.
• Translational research.
• Cancer therapy (target discovery, drug design, immunotherapy, combination therapies, resistance, and individualised treatment).
• Chemotherapy, radiotherapy and surgery.
• Clinical pharmacology.
• Clinical trials, integration of basic science into cancer clinical trials.
• Epidemiology and prevention.
• Infrastructures (biobanks, databases, genomic resources).
A main feature of the Journal is to provide an international forum for debating cancer issues, and for integrating the input of all the stakeholders.
Nature Reviews Cancer
Nature Reviews Cancer will be a gateway from which cancer researchers — from those investigating the molecular basis of cancer to those involved in translational research — access the information that they need to further the ability to diagnose, treat and ultimately prevent cancer.
Oncogene is published weekly and covers the structure and function of oncogenes.